首页> 美国卫生研究院文献>Proteome Science >Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae
【2h】

Proteomic and immunoproteomic characterization of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae

机译:抗胸膜肺炎放线杆菌DIVA亚基疫苗的蛋白质组学和免疫蛋白质组学表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundProtection of pigs by vaccination against Actinobacillus pleuropneumoniae, the causative agent of porcine pleuropneumonia, is hampered by the presence of 15 different serotypes. A DIVA subunit vaccine comprised of detergent-released proteins from A. pleuropneumoniae serotypes 1, 2 and 5 has been developed and shown to protect pigs from clinical symptoms upon homologous and heterologous challenge. This vaccine has not been characterized in-depth so far. Thus we performed i) mass spectrometry in order to identify the exact protein content of the vaccine and ii) cross-serotype 2-D immunoblotting in order to discover cross-reactive antigens. By these approaches we expected to gain results enabling us to argue about the reasons for the efficacy of the analyzed vaccine.
机译:背景技术猪胸膜肺炎放线杆菌(猪胸膜肺炎的致病因子)的疫苗接种对猪的保护受到15种不同血清型的阻碍。已经开发了一种DIVA亚单位疫苗,该疫苗包含来自胸膜肺炎链球菌血清型1、2和5的去污剂释放蛋白,可在同种和异种攻击下保护猪免受临床症状侵害。到目前为止,尚未对该疫苗进行深入表征。因此,我们进行了i)质谱分析以鉴定疫苗的确切蛋白质含量,ii)进行交叉血清型2-D免疫印迹以发现交叉反应性抗原。通过这些方法,我们有望获得结果,使我们能够辩论所分析疫苗功效的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号